Use of Transarterial Chemoembolization (TACE) and Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: US Regional Analysis of the GIDEON Registry

BACKGROUND: Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Treatment with Sorafenib (GIDEON) is a worldwide, prospective, non-interventional study to evaluate the safety of sorafenib in a variety of patient subsets. METHODS: Eligible patients had unresectable hepato...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Liver Cancer
Auteurs principaux: Geschwind, Jean-Francois H., Gholam, Pierre M., Goldenberg, Alec, Mantry, Parvez, Martin, Robert C. G., Piperdi, Bilal, Zigmont, Ellen, Imperial, Joanne, Babajanyan, Svetlana, Foreman, Pamela K., Cohn, Allen
Format: Artigo
Langue:Inglês
Publié: S. Karger AG 2016
Sujets:
Original Paper
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4789900/
https://ncbi.nlm.nih.gov/pubmed/26989658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000367757
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires